Skip to main content

International Commission on the Clinical Use of Human Germline Genome Editing

Completed

An international commission has been convened by the U.S. National Academy of Medicine, the U.S. National Academy of Sciences, and the U.K.’s Royal Society, with the participation of academies of sciences and medicine from around the world. The commission will develop a framework for scientists, clinicians, and regulatory authorities to consider when assessing potential clinical applications of human germline genome editing, should society conclude that heritable human genome editing applications are acceptable.

Featured publication

Consensus

·

2020

Heritable human genome editing - making changes to the genetic material of eggs, sperm, or any cells that lead to their development, including the cells of early embryos, and establishing a pregnancy - raises not only scientific and medical considerations but also a host of ethical, moral, and socie...

View details

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.